Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.

NCT00002175 is registered in ClinicalTrials.gov with The Honolulu Medical Group as lead sponsor.

NCT NCT00002175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.
Lead sponsor
The Honolulu Medical Group
Phase
Phase 1
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
46
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections